Deep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's Disease

This study employs an exploratory, prospective, single center, naturalistic clinical trial design with a randomized crossover intervention.

Study identifier: NCT07110376. Status: RECRUITING. Phase: NA.

Eligibility

Criteria: Inclusion Criteria: * Male or female \> 18 years of age * Diagnosed with idiopathic Parkinson Disease * Have bilateral implantation of Medtronic's PerceptTM PC (Medtronic Neurological Division, Minneapolis, MN, USA) Deep Brain Stimulation (DBS) system targeting the subthalamic nucleus (STN) and have had their stimulation settings optimized for a minimum of three months * Report a response score of one or greater on question 1.7 of the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part I; * Demonstrate ability to ambulate independently; * Be capable of providing informed consent; * If taking sleep-supporting medications, dosing must be stable for at least 30 days Exclusion Criteria: * Presence of neurological diseases other than Parkinson Disease, such as stroke or multiple sclerosis * Active sleep disorders, including narcolepsy, moderate to severe (Apnea-Hypopnea Index\>=15) untreated sleep apnea, uncontrolled restless legs syndrome * Cognitive impairment meeting the criteria for dementia as per the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV), based on formal neuropsychological evaluation * Ongoing alcohol or substance abuse; Working night shifts or irregular work hours The main concern for vulnerable subjects will be for the possibility of reduced decision-making capacity. For this we intend to exclude individuals who have a diagnosis of dementia.

  • Minimum age: 18 Years

Participating locations

  • Cleveland Clinic, Cleveland, Ohio

Study records are sourced from ClinicalTrials.gov. Confirm current eligibility, recruiting status, and locations in the official record.

View the official ClinicalTrials.gov record for NCT07110376

Browse Parkinson's clinical trials